TPX2 as a prognostic indicator and potential therapeutic target in clear cell renal cell carcinomaZachary A. Glaser, Peter E. Clark, Sam S. Chang et al.|Urologic Oncology Seminars and Original Investigations|2017Cited by 33
Pharmacologic Inhibition of β-Catenin With Pyrvinium Inhibits Murine and Human Models of Wilms TumorDina Polosukhina, Peter E. Clark, Harold D. Love et al.|Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics|2017Cited by 11